Challapalli, A., Bahl, A., Venugopal, B., Afshar, M., Alifrangis, C., Thomson, A., Tran, A., Hudson, A., Kent, C., Barber, J., Dearden, H. C., Pearson, R., Kumar, V., Wade, R., Bravo, A., White, P., Foulstone, E. (2025). EPIC-B: Phase II trial of cemiplimab as first-line treatment in advanced penile carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.9